CN Patent
CN107205949A — 包含片芯和立即释放包衣的用于口服glp‑1给药的药物组合物
Assigned to Novo Nordisk AS · Expires 2017-09-26 · 9y expired
What this patent protects
本发明涉及包含片芯和立即释放包衣的药物组合物,其中所述片芯包含GLP‑1肽和吸收增强剂,并且涉及其用途。
USPTO Abstract
本发明涉及包含片芯和立即释放包衣的药物组合物,其中所述片芯包含GLP‑1肽和吸收增强剂,并且涉及其用途。
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.